Creative Planning
MDCO

Creative Planning’s Medicines Co MDCO Stock Holding History

Creative Planning’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-66,742
Closed -$3.34M – 2156
2019
Q3 		$3.34M Sell
66,742
-9,500
-12% -$379K 0.01% 367
2019
Q2 		$2.78M Buy
76,242
+9,990
+15% +$326K 0.01% 409
2019
Q1 		$1.85M Hold
66,252
– – 0.01% 489
2018
Q4 		$1.27M Sell
66,252
-25
-0% -$582 0.01% 576
2018
Q3 		$1.98M Sell
66,277
-15,000
-18% -$565K 0.01% 484
2018
Q2 		$2.98M Sell
81,277
-9,240
-10% -$300K 0.01% 378
2018
Q1 		$2.98M Sell
90,517
-10,378
-10% -$324K 0.01% 368
2017
Q4 		$2.76M Sell
100,895
-49,940
-33% -$1.54M 0.01% 379
2017
Q3 		$5.59M Sell
150,835
-65
-0% -$2.4K 0.03% 219
2017
Q2 		$5.74M Buy
150,900
+150,870
+502,900% +$6.72M 0.03% 201
2017
Q1 		$1K Sell
30
-300
-91% -$13.7K ﹤0.01% 4555
2016
Q4 		$11K Buy
330
+30
+10% +$1.06K ﹤0.01% 3521
2016
Q3 		$11K Buy
300
+200
+200% +$7.54K ﹤0.01% 3476
2016
Q2 		$3K Hold
100
– – ﹤0.01% 3941
2016
Q1 		$3K Hold
100
– – ﹤0.01% 3861
2015
Q4 		$4K Hold
100
– – ﹤0.01% 3835
2015
Q3 		$4K Buy
+100
New +$3.51K ﹤0.01% 3763
2015
Q2 		– Sell
-2,000
Closed -$56K – 3495
2015
Q1 		$56K Sell
2,000
-3,000
-60% -$84.3K ﹤0.01% 1955
2014
Q4 		$138K Sell
5,000
-4,000
-44% -$99.1K ﹤0.01% 1368
2014
Q3 		$201K Hold
9,000
– – ﹤0.01% 1051
2014
Q2 		$262K Sell
9,000
-2,000
-18% -$53.4K ﹤0.01% 910
2014
Q1 		$313K Buy
11,000
+6,000
+120% +$199K ﹤0.01% 798
2013
Q4 		$193K Sell
5,000
-1,150
-19% -$41.1K ﹤0.01% 876
2013
Q3 		$206K Sell
6,150
-2,850
-32% -$90.8K ﹤0.01% 756
2013
Q2 		$277K Buy
+9,000
New +$301K 0.01% 578

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Creative Planning's MDCO Position: Q4 2019 in Review

Creative Planning sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 66,742 shares — an estimated $3.34M sold.

Creative Planning first reported a position in MDCO in Q2 2013 and held it in 25 quarters. The position peaked at $5.74M in Q2 2017. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Creative Planning reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Creative Planning sold 66,742 Medicines Co shares in Q4 2019, an estimated $3.34M.
  • Creative Planning first reported a position in Medicines Co in Q2 2013 and held it in 25 quarters.
  • Creative Planning's Medicines Co position peaked at $5.74M in Q2 2017.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Creative Planning's 13F filing for Q4 2019, filed 30 Jan 2020.